Adult antiretroviral therapy guidelines 2017

Adult antiretroviral therapy guidelines 2017

These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in 2014 and the update on when to initiate antiretroviral therapy in 2015. Since the release of the previous guidelines, the scale-up of antiretroviral therapy (ART) in southern Africa has c...

Full description

Bibliographic Details
Main Authors:	Graeme Meintjes, Michelle A. Moorhouse, Sergio Carmona, Natasha Davies, Sipho Dlamini, Cloete van Vuuren, Thandekile Manzini, Moeketsi Mathe, Yunus Moosa, Jennifer Nash, Jeremy Nel, Yoliswa Pakade, Joana Woods, Gert van Zyl, Francesca Conradie, Francois Venter
Format:	Article
Language:	English
Published:	AOSIS 2017-07-01
Series:	Southern African Journal of HIV Medicine
Online Access:	https://sajhivmed.org.za/index.php/hivmed/article/view/776

Similar Items

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
by: Michelle A. Moorhouse, et al.
Published: (2018-10-01)

Appropriate clinical use of darunavir 800 mg
by: Michelle A. Moorhouse, et al.
Published: (2018-10-01)

Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy
by: Graeme Meintjes, et al.
Published: (2015-12-01)

Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
by: Jeremy Nel, et al.
Published: (2020-09-01)

What is the role of CD4 count in a large public health antiretroviral programme?
by: Michelle Moorhouse, et al.
Published: (2016-02-01)

Paraquat poisoning: Acute lung injury – a missed diagnosis
by: Sipho D Ntshalintshali, et al.
Published: (2017-05-01)

2023 Southern African HIV Clinicians Society Adult Antiretroviral Therapy Guidelines: What’s new?
by: Jeremy Nel, et al.
Published: (2023-09-01)

Rapid emergence of resistance to antiretroviral treatment after undisclosed prior exposure: A case report
by: Theresa M. Rossouw, et al.
Published: (2019-07-01)

Adult antiretroviral therapy guidelines 2014
by: G. Meintjes
Published: (2014-01-01)

Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.
by: Geoffrey Fatti, et al.
Published: (2014-01-01)

#FeesMustFall: Lessons from the Post‑colonial Global South
by: Sipho Dlamini
Published: (2019-09-01)

Efavirenz challenge in patients with nevirapine induced Stevens-Johnson Syndrome
by: Thandekile C. Manzini, et al.
Published: (2016-12-01)

Multisystem cytomegalovirus end-organ disease in a patient with advanced HIV
by: Ruan Spies, et al.
Published: (2022-11-01)

Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.
by: Dominique J Pepper, et al.
Published: (2011-05-01)

Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis.
by: Helen van der Plas, et al.
Published: (2013-01-01)

Case Report: Stevens-Johnson syndrome following a single double dosing of nevirapine-containing regimen once in an HIV-infected woman on long-term antiretroviral therapy. [version 1; referees: 1 approved, 2 approved with reservations]
by: Betty Kakande, et al.
Published: (2015-06-01)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
by: Kairoonisha Mahomed, et al.
Published: (2020-07-01)

Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
by: Kim Steegen, et al.
Published: (2016-01-01)

Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial
by: Zhao, Y, et al.
Published: (2023)

Tuberculous drug-induced liver injury and treatment re-challenge in Human Immunodeficiency Virus co-infection
by: Cecilia T Costiniuk, et al.
Published: (2015-01-01)

Guidelines for antiretroviral therapy in adults
by: G Meintjes, et al.
Published: (2012-08-01)

Early severe morbidity and resource utilization in South African adults on antiretroviral therapy
by: Meintjes Graeme A, et al.
Published: (2009-12-01)

Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic
by: Toby Pepperrell, et al.
Published: (2020-04-01)

Intrapartum human immunodeficiency virus transmission rate in a central hospital in the Western Cape province after universal antiretroviral therapy roll-out
by: Tian A. van der Merwe, et al.
Published: (2020-12-01)

Loss to follow-up from antiretroviral therapy clinics: A systematic review and meta-analysis of published studies in South Africa from 2011 to 2015
by: Samantha Kaplan, et al.
Published: (2019-12-01)

SIBU and the crisis of water service delivery in Sannieshof, North West Province
by: C Gouws, et al.
Published: (2010-04-01)

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens.
by: Gert U Van Zyl, et al.
Published: (2013-01-01)

Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy.
by: Kenneth Crombie, et al.
Published: (2018-03-01)

Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment
by: Marlene Knight, et al.
Published: (2015-10-01)

Optimised paediatric antiretroviral treatment to achieve the 95-95-95 goals
by: Moherndran Archary, et al.
Published: (2021-09-01)

Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial
by: Willem D. F. Venter, et al.
Published: (2017-07-01)

Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients.
by: Dominique J Pepper, et al.
Published: (2012-01-01)

Reduced referral and case fatality rates for severe symptomatic hyperlactataemia in a South African public sector antiretroviral programme: a retrospective observational study
by: Stead Dave, et al.
Published: (2010-05-01)

Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks
by: Keene, CM, et al.
Published: (2023)

Comparing Class-Aware and Pairwise Loss Functions for Deep Metric Learning in Wildlife Re-Identification
by: Nkosikhona Dlamini, et al.
Published: (2021-09-01)

A case series of emtricitabine-induced pure red cell aplasia
by: Nithendra Manickchund, et al.
Published: (2021-08-01)

Evaluating a minipool strategy to screen for virologic failure and antiretroviral drug resistance
by: H.M. Newman, et al.
Published: (2014-04-01)

Behavioural involvement in avitourism: An international case study.
by: Mrs N. Conradie, et al.
Published: (2016-02-01)

Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life
by: Barbara Laughton, et al.
Published: (2019-10-01)

Hope and challenges working at the frontiers of medical knowledge
by: Graeme Meintjes
Published: (2022-02-01)